Astellas Pharma saw the highest growth of 127% in patent filings and 339% in grants in August in Q3 2023. Compared to Q2 2023, Q3 2023 saw an increase in patent filings by 77% and grants by 41%. GlobalData’s DataBook provides a comprehensive analysis of Astellas Pharma‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Astellas Pharma has been focused on protecting inventions in United States(US) with 25 publications in Q3 2023
The United States(US) Patent Office dominates the patent filings and grants with nearly 19% filings and 36% grants. The United States(US), Australia(AU), South Korea(KR), and European Patent Office(EPO) patent Office are among the top ten patent offices where Astellas Pharma is filings its patents. Among the top granted patent authorities, Astellas Pharma has 36% of its grants in United States(US), 12% in European Patent Office(EPO), and 6% in Australia(AU).
Johnson & Johnson could be the strongest competitor for Astellas Pharma
Johnson & Johnson and Pfizer secured the top positions according to recent patent publication data.
Patents related to rare diseases and healthtech lead Astellas Pharma's portfolio
Astellas Pharma has the highest number of patents in rare diseases followed by, healthtech and remote patient monitoring. For rare diseases, nearly 54% of patents were filed and 56% of patents were granted in Q3 2023.
Pancreatic cancer related patents lead Astellas Pharma portfolio followed by ovarian cancer, and lung cancer
Astellas Pharma has highest number of patents in pancreatic cancer followed by ovarian cancer, lung cancer, mobiles, hand-helds, pdas, smartphones and esophageal cancer. For pancreatic cancer, nearly 5% of patents were filed and 4% of patents were granted in Q3 2023.
For comprehensive analysis of Astellas Pharma's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
